Search
for
Sort by
Research 691–720 of 1000+
- A diagnostic clue: New onset alopecia sparing white hairs
- Treatment preferences of adults and adolescents with alopecia areata: A discrete choice experiment
- Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study
- Nanotechnology-based techniques for hair follicle regeneration
- 42752 Evaluation of Eyebrow and Eyelash Regrowth and Patient Satisfaction in the Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata
- Topical metformin as a novel therapy for alopecia areata due to its immunologic effects
- Treatment Patterns and Unmet Needs in the Management of Alopecia Areata: Results of a Physician’s Survey in the Middle East
- Evaluation of the Awareness, Beliefs, and Psychological Impact of Patients with Alopecia Areata in Makkah City, Saudi Arabia
- Janus kinase inhibitor as a therapeutic option in alopecia areata. Case report
- Hypoxia enhances the hair growth-promoting effects of embryonic stem cell-derived mesenchymal stem cells via NADPH oxidase 4
- Efficacy and Safety of Platelet-Rich Plasma Therapy in Alopecia Areata Patients: A Systematic Review
- Alopecia Areata
- Signposts to the Promised Land in Alopecia Areata
- Reply to early onset effluvium secondary to COVID-19 and body-hair effluvium
- The changing landscape of managing hair loss: a 30‐year perspective
- Alopecia Totalis Treated with 1064 nm Picosecond Nd:YAG Laser: A Case Report
- The Good and Bad News About New Drugs for Treating Alopecia Areata
- Long‐Term Use of Tralokinumab in Patients With Atopic Dermatitis: A Real‐World Multicentric Case Series
- Top 10 Facts: Common Hair Loss Causes and Management in Patients
- The JAK/STAT signaling pathway: from bench to clinic
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
- JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
- Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata
- Pharmacologic inhibition of JAK-STAT signaling promotes hair growth
- COVID-19: Pulmonary and Extra Pulmonary Manifestations
- Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review
- Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population